Skip to main content
Figure 6 | Malaria Journal

Figure 6

From: The initial pharmaceutical development of an artesunate/amodiaquine oral formulation for the treatment of malaria: a public-private partnership

Figure 6

Dissolution profiles of AS and AQ bilayer ASAQ tablets compared to commercially available reference tablets. Key: Panel A: dissolution profiles of AS in high (30154C03) and low (30154C04) dosage bilayer ASAQ tablets compared to commercialized AS tablets Arsumax®

Panel B: dissolution profiles of AQ of high (30154C03) and low (30154C04) dosage bilayer ASAQ tablets compared to commercialized AQ tablets Flavoquine®.

Back to article page

Malaria Journal

ISSN: 1475-2875

Contact us